REPORT ID 680

EMEA (Europe, Middle East and Africa) Cardiac Biomarkers Market Report 2019

Publish Date
2019
Pages
103
Format
Electronic (PDF)

In this report, the EMEA Cardiac Biomarkers market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Cardiac Biomarkers for these regions, from   2019 to 2025 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Cardiac Biomarkers market competition by top manufacturers/players, with Cardiac Biomarkers sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Abbott Laboratories
    Alere
    Siemens Healthcare GmbH
    Roche Diagnostics Corporation
    Beckman Coulter, Inc.
    BG Medicines
    Thermo Fisher Scientific, Inc.
    BioMerieux SA
    Bio-Rad Laboratories

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Troponin
    LDH isoenzymes
    Myoglobin
    Ischemia Modified Albumin (IMA)
    Heart-type Fatty Acid Binding Protein (H-FABP)

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Acute Coronary Syndrome
    Myocardial Infarction
    Congestive Heart Failure
    Cardiomyopathy
    Ischemia
    Myocarditis
    Atrial Fibrillation

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Cardiac Biomarkers Market  Report 2019
1 Cardiac Biomarkers Overview
    1.1 Product Overview and Scope of Cardiac Biomarkers
    1.2 Classification of Cardiac Biomarkers
        1.2.1 EMEA Cardiac Biomarkers Market Size (Sales) Comparison by Type ( 2014-2024)
        1.2.2 EMEA Cardiac Biomarkers Market Size (Sales) Market Share by Type (Product Category)  in 2018
        1.2.3 Troponin
        1.2.4 LDH isoenzymes
        1.2.5 Myoglobin
        1.2.6 Ischemia Modified Albumin (IMA)
        1.2.7 Heart-type Fatty Acid Binding Protein (H-FABP)
    1.3 EMEA Cardiac Biomarkers Market by Application/End Users
        1.3.1 EMEA Cardiac Biomarkers Sales (Volume) and Market Share Comparison by Application ( 2014-2024
        1.3.2 Acute Coronary Syndrome
        1.3.3 Myocardial Infarction
        1.3.4 Congestive Heart Failure
        1.3.5 Cardiomyopathy
        1.3.6 Ischemia
        1.3.7 Myocarditis
        1.3.8 Atrial Fibrillation
    1.4 EMEA Cardiac Biomarkers Market by Region
        1.4.1 EMEA Cardiac Biomarkers Market Size (Value) Comparison by Region ( 2014-2024)
        1.4.2 Europe Status and Prospect ( 2014-2024)
        1.4.3 Middle East Status and Prospect ( 2014-2024)
        1.4.4 Africa Status and Prospect ( 2014-2024)
    1.5 EMEA Market Size (Value and Volume) of Cardiac Biomarkers ( 2014-2024)
        1.5.1 EMEA Cardiac Biomarkers Sales and Growth Rate ( 2014-2024)
        1.5.2 EMEA Cardiac Biomarkers Revenue and Growth Rate ( 2014-2024)

2 EMEA Cardiac Biomarkers Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Cardiac Biomarkers Market Competition by Players/Manufacturers
        2.1.1 EMEA Cardiac Biomarkers Sales Volume and Market Share of Major Players ( 2014-2019)
        2.1.2 EMEA Cardiac Biomarkers Revenue and Share by Players ( 2014-2019)
        2.1.3 EMEA Cardiac Biomarkers Sale Price by Players ( 2014-2019)
    2.2 EMEA Cardiac Biomarkers (Volume and Value) by Type/Product Category
        2.2.1 EMEA Cardiac Biomarkers Sales and Market Share by Type ( 2014-2019)
        2.2.2 EMEA Cardiac Biomarkers Revenue and Market Share by Type ( 2014-2019)
        2.2.3 EMEA Cardiac Biomarkers Sale Price by Type ( 2014-2019)
    2.3 EMEA Cardiac Biomarkers (Volume) by Application
    2.4 EMEA Cardiac Biomarkers (Volume and Value) by Region
        2.4.1 EMEA Cardiac Biomarkers Sales and Market Share by Region ( 2014-2019)
        2.4.2 EMEA Cardiac Biomarkers Revenue and Market Share by Region ( 2014-2019)
        2.4.3 EMEA Cardiac Biomarkers Sales Price by Region ( 2014-2019)

3 Europe Cardiac Biomarkers (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Cardiac Biomarkers Sales and Value ( 2014-2019)
        3.1.1 Europe Cardiac Biomarkers Sales Volume and Growth Rate ( 2014-2019)
        3.1.2 Europe Cardiac Biomarkers Revenue and Growth Rate ( 2014-2019)
    3.2 Europe Cardiac Biomarkers Sales and Market Share by Type
    3.3 Europe Cardiac Biomarkers Sales and Market Share by Application
    3.4 Europe Cardiac Biomarkers Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Cardiac Biomarkers Sales Volume by Countries ( 2014-2019)
        3.4.2 Europe Cardiac Biomarkers Revenue by Countries ( 2014-2019)
        3.4.3 Germany Cardiac Biomarkers Sales and Growth Rate ( 2014-2019)
        3.4.4 France Cardiac Biomarkers Sales and Growth Rate ( 2014-2019)
        3.4.5 UK Cardiac Biomarkers Sales and Growth Rate ( 2014-2019)
        3.4.6 Russia Cardiac Biomarkers Sales and Growth Rate ( 2014-2019)
        3.4.7 Italy Cardiac Biomarkers Sales and Growth Rate ( 2014-2019)
        3.4.8 Benelux Cardiac Biomarkers Sales and Growth Rate ( 2014-2019)

4 Middle East Cardiac Biomarkers (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Cardiac Biomarkers Sales and Value ( 2014-2019)
        4.1.1 Middle East Cardiac Biomarkers Sales Volume and Growth Rate ( 2014-2019)
        4.1.2 Middle East Cardiac Biomarkers Revenue and Growth Rate ( 2014-2019)
    4.2 Middle East Cardiac Biomarkers Sales and Market Share by Type
    4.3 Middle East Cardiac Biomarkers Sales and Market Share by Application
    4.4 Middle East Cardiac Biomarkers Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Cardiac Biomarkers Sales Volume by Countries ( 2014-2019)
        4.4.2 Middle East Cardiac Biomarkers Revenue by Countries ( 2014-2019)
        4.4.3 Saudi Arabia Cardiac Biomarkers Sales and Growth Rate ( 2014-2019)
        4.4.4 Israel Cardiac Biomarkers Sales and Growth Rate ( 2014-2019)
        4.4.5 UAE Cardiac Biomarkers Sales and Growth Rate ( 2014-2019)
        4.4.6 Iran Cardiac Biomarkers Sales and Growth Rate ( 2014-2019)

5 Africa Cardiac Biomarkers (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Cardiac Biomarkers Sales and Value ( 2014-2019)
        5.1.1 Africa Cardiac Biomarkers Sales Volume and Growth Rate ( 2014-2019)
        5.1.2 Africa Cardiac Biomarkers Revenue and Growth Rate ( 2014-2019)
    5.2 Africa Cardiac Biomarkers Sales and Market Share by Type
    5.3 Africa Cardiac Biomarkers Sales and Market Share by Application
    5.4 Africa Cardiac Biomarkers Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Cardiac Biomarkers Sales Volume by Countries ( 2014-2019)
        5.4.2 Africa Cardiac Biomarkers Revenue by Countries ( 2014-2019)
        5.4.3 South Africa Cardiac Biomarkers Sales and Growth Rate ( 2014-2019)
        5.4.4 Nigeria Cardiac Biomarkers Sales and Growth Rate ( 2014-2019)
        5.4.5 Egypt Cardiac Biomarkers Sales and Growth Rate ( 2014-2019)
        5.4.6 Algeria Cardiac Biomarkers Sales and Growth Rate ( 2014-2019)

6 EMEA Cardiac Biomarkers Manufacturers/Players Profiles and Sales Data
    6.1 Abbott Laboratories
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Cardiac Biomarkers Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Abbott Laboratories Cardiac Biomarkers Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.1.4 Main Business/Business Overview
    6.2 Alere
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Cardiac Biomarkers Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Alere Cardiac Biomarkers Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.2.4 Main Business/Business Overview
    6.3 Siemens Healthcare GmbH
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Cardiac Biomarkers Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Siemens Healthcare GmbH Cardiac Biomarkers Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.3.4 Main Business/Business Overview
    6.4 Roche Diagnostics Corporation
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Cardiac Biomarkers Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Roche Diagnostics Corporation Cardiac Biomarkers Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.4.4 Main Business/Business Overview
    6.5 Beckman Coulter, Inc.
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Cardiac Biomarkers Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Beckman Coulter, Inc. Cardiac Biomarkers Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.5.4 Main Business/Business Overview
    6.6 BG Medicines
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Cardiac Biomarkers Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 BG Medicines Cardiac Biomarkers Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.6.4 Main Business/Business Overview
    6.7 Thermo Fisher Scientific, Inc.
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Cardiac Biomarkers Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Thermo Fisher Scientific, Inc. Cardiac Biomarkers Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.7.4 Main Business/Business Overview
    6.8 BioMerieux SA
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Cardiac Biomarkers Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 BioMerieux SA Cardiac Biomarkers Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.8.4 Main Business/Business Overview
    6.9 Bio-Rad Laboratories
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Cardiac Biomarkers Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Bio-Rad Laboratories Cardiac Biomarkers Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.9.4 Main Business/Business Overview

7 Cardiac Biomarkers Manufacturing Cost Analysis
    7.1 Cardiac Biomarkers Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Cardiac Biomarkers

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Cardiac Biomarkers Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Cardiac Biomarkers Major Manufacturers  in 2018
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Cardiac Biomarkers Market Forecast ( 2019-2025)
    11.1 EMEA Cardiac Biomarkers Sales, Revenue and Price Forecast ( 2019-2025)
        11.1.1 EMEA Cardiac Biomarkers Sales and Growth Rate Forecast ( 2019-2025)
        11.1.2 EMEA Cardiac Biomarkers Revenue and Growth Rate Forecast ( 2019-2025)
        11.1.3 EMEA Cardiac Biomarkers Price and Trend Forecast ( 2019-2025)
    11.2 EMEA Cardiac Biomarkers Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.3 Europe Cardiac Biomarkers Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.4 Middle Eastt Cardiac Biomarkers Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.5 Africa Cardiac Biomarkers Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.6 EMEA Cardiac Biomarkers Sales Forecast by Type ( 2019-2025)
    11.7 EMEA Cardiac Biomarkers Sales Forecast by Application ( 2019-2025)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer